Literature DB >> 22627862

The impact of infection and tissue damage in solid-organ transplantation.

Anita S Chong1, Maria-Luisa Alegre.   

Abstract

Investigations over the past two decades are revealing complexities in the regulation of the innate immune response, and how this response, in turn, controls adaptive immunity. Microbial exposure, infections and tissue damage that accompany solid-organ transplantation result in the release of pathogen- and damage-associated molecular patterns, as well as pathogen- or allograft-derived antigens. Here, we review these triggers of innate and adaptive immunity, and discuss emerging paradigms of the many ways in which infections and tissue damage might directly or indirectly affect alloreactivity and the outcome of transplanted allografts.

Entities:  

Mesh:

Year:  2012        PMID: 22627862      PMCID: PMC4053185          DOI: 10.1038/nri3215

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  110 in total

1.  Diet, gut microbiota and immune responses.

Authors:  Kendle M Maslowski; Charles R Mackay
Journal:  Nat Immunol       Date:  2011-01       Impact factor: 25.606

Review 2.  Special considerations for patients with cystic fibrosis undergoing lung transplantation.

Authors:  Denis Hadjiliadis
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

Review 3.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

4.  The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppression dependent.

Authors:  Margreet Jonker; Anna Danskine; Krista Haanstra; Jacqueline Wubben; Ivanela Kondova; Eva-Maria Kuhn; Marlene Rose
Journal:  Transplantation       Date:  2005-08-15       Impact factor: 4.939

5.  Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.

Authors:  R M Welsh; T G Markees; B A Woda; K A Daniels; M A Brehm; J P Mordes; D L Greiner; A A Rossini
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation.

Authors:  Elisabeth A Kastelijn; Coline H M van Moorsel; Ger T Rijkers; Henk J T Ruven; Vincent Karthaus; Johanna M Kwakkel-van Erp; E A van de Graaf; Pieter Zanen; Diana A van Kessel; Jan C Grutters; Jules M M van den Bosch
Journal:  J Heart Lung Transplant       Date:  2010-03-15       Impact factor: 10.247

Review 7.  TLR-dependent T cell activation in autoimmunity.

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2011-11-18       Impact factor: 53.106

8.  Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.

Authors:  Scott M Palmer; Lauranell H Burch; Saad Mir; Stephen R Smith; Paul C Kuo; Walter F Herczyk; Nancy L Reinsmoen; David A Schwartz
Journal:  Clin Transplant       Date:  2006 Jan-Feb       Impact factor: 2.863

9.  Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.

Authors:  C H Cook; A A Bickerstaff; J-J Wang; P D Zimmerman; M R Forster; T Nadasdy; R B Colvin; G A Hadley; C G Orosz
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

10.  Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.

Authors:  Tim A Weaver; Ali H Charafeddine; Avinash Agarwal; Alexandra P Turner; Maria Russell; Frank V Leopardi; Robert L Kampen; Linda Stempora; Mingqing Song; Christian P Larsen; Allan D Kirk
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

View more
  55 in total

Review 1.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

2.  Transplantation preferentially induces a KLRG-1lo CD127hi differentiation program in antigen-specific CD8+ T cells.

Authors:  Alana M Bozeman; Sonia J Laurie; Divya Haridas; Maylene E Wagener; Mandy L Ford
Journal:  Transpl Immunol       Date:  2018-06-08       Impact factor: 1.708

Review 3.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

Review 4.  Danger signals in regulating the immune response to solid organ transplantation.

Authors:  Jamie L Todd; Scott M Palmer
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

Review 5.  Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

Authors:  Herman Waldmann; Robert Hilbrands; Duncan Howie; Stephen Cobbold
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

Review 6.  Advances in islet encapsulation technologies.

Authors:  Tejal Desai; Lonnie D Shea
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

7.  Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.

Authors:  R Ettenger; H Chin; K Kesler; N Bridges; P Grimm; E F Reed; M Sarwal; R Sibley; E Tsai; B Warshaw; A D Kirk
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

Review 8.  Innate allorecognition by monocytic cells and its role in graft rejection.

Authors:  F G Lakkis; X C Li
Journal:  Am J Transplant       Date:  2017-08-24       Impact factor: 8.086

9.  Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome.

Authors:  Patricia I Diaz; Bo-Young Hong; Jorge Frias-Lopez; Amanda K Dupuy; Mark Angeloni; Loreto Abusleme; Evimaria Terzi; Effie Ioannidou; Linda D Strausbaugh; Anna Dongari-Bagtzoglou
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

10.  The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.

Authors:  Peter Urbanellis; Wendy Shyu; Ramzi Khattar; Jihong Wang; Anna Zakharova; Wei He; Hassan Sadozai; Achiya Z Amir; Itay Shalev; M James Phillips; Oyedele Adeyi; Heather Ross; David Grant; Gary A Levy; Andrzej Chruscinski
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.